• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AWS & MATTER Launches Incubator for EMEA Healthcare Startups Entering US Market

Share:

June 29, 2022

– Amazon Web Services (AWS) and MATTER, the premier healthcare incubator, and innovation hub, announced the launch of a new incubation program called AWS Expand.

– The program supports startups entering the US market from Europe, the Middle East, and Africa (EMEA) by providing expert guidance, mentorship, client connections, an extensive network within the healthcare industry, and more.

AWS Expand’s First Cohort of 30 EMA Healthcare Startups

The dual-track program will prepare Europe, the Middle East, and Africa (EMEA) based startups to enter and understand the intricacies of the U.S. healthcare market through education, mentorship, and exposure to potential customers and partners. The first track will welcome 30 EMEA-based healthcare startups to the MATTER community as members for three months beginning this summer. As MATTER members, the startups will have access to MATTER’s robust investor and industry network, strategic connections to potential customers, a mentoring clinic with 350 industry experts who serve as MATTER mentors, exclusive invitations to curated forums with industry leaders, and a curriculum with more than 100 workshops on topics including the FDA approval, reimbursement, intellectual property, and sales strategy.

The second track will identify an additional eight startups to participate in a high-touch, eight-week incubator concentrated on curating introductions to key potential U.S. customers through both one-on-one and group sessions. The incubator will culminate in a demo day, with the cohort presenting their solutions to a panel of industry stakeholders. Applications for both programs open in July, and the program will end in November.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“AWS is committed to helping healthcare startups across the globe find new opportunities and scale their businesses, and that often means expanding beyond their own borders,” said Jared Saul, MD, global lead for healthcare & life sciences startups and investors at AWS. “We look forward to working with MATTER to give EMEA-based companies the tools, knowledge, and connections to successfully enter the U.S. market.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pharma & Cosmetics Market Size and Growth 2021-2027Pharma & Cosmetics Market Size and Growth 2021-2027
  • Global Graft Versus Host Disease – Market Insight, Epidemiology and Market Forecast – 2030Global Graft Versus Host Disease – Market Insight, Epidemiology and Market Forecast – 2030
  • Wearables and Remote Patient Monitoring Market MapWearables and Remote Patient Monitoring Market Map
  • STERIS Completes the Acquisition of Cantel MedicalSTERIS Completes the Acquisition of Cantel Medical
  • Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT BiopharmaLilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma
  • Astellas buys gene therapy company QuetheraAstellas buys gene therapy company Quethera
  • Mercy Virtual Leads $10M Investment in Myia Labs, Rolls out Home Monitoring tech to PatientsMercy Virtual Leads $10M Investment in Myia Labs, Rolls out Home Monitoring tech to Patients
  • ResApp Awarded CE Mark For Smartphone-Based Diagnostic Test For Respiratory DiseaseResApp Awarded CE Mark For Smartphone-Based Diagnostic Test For Respiratory Disease

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications